SEC Comment Letter 0000000000-24-002193 to Microbot Medical Inc. (MBOT)

Microbot Medical Inc.
Date: Feb. 27, 2024 · CIK: 0000883975 · Accession: 0000000000-24-002193

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-277190

Date

February 27, 2024

Author

Not clearly detected

Form

UPLOAD

Company

Microbot Medical Inc.

Letter

United States securities and exchange commission logo February 27, 2024 Harel Gadot Chief Executive Officer Microbot Medical Inc. 288 Grove Street, Suite 388 Braintree, MA 02184 Re:Microbot Medical Inc. Registration Statement on Form S-1 Filed February 20, 2024 File No. 333-277190 Dear Harel Gadot: Our initial review of your registration statement indicates that it fails in numerous material respects to comply with the requirements of the Securities Act of 1933, the rules and regulations thereunder and the requirements of the form. More specifically,

Please revise your filing to include audited financial statements for the fiscal year ended December 31, 2023 to comply with Rule 8-08 of Regulation S-X, along with related updated financial information.

We will provide more detailed comments relating to your registration statement following our review of a substantive amendment that addresses these deficiencies. Please contact Juan Grana at 202-551-6034 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Stephen E. Fox, Esq.

Show Raw Text

United States securities and exchange commission logo
February 27, 2024
Harel Gadot
Chief Executive Officer
Microbot Medical Inc.
288 Grove Street, Suite 388
Braintree, MA 02184
Re:Microbot Medical Inc.
Registration Statement on Form S-1
Filed February 20, 2024
File No. 333-277190
Dear Harel Gadot:
            Our initial review of your registration statement indicates that it fails in numerous
material respects to comply with the requirements of the Securities Act of 1933, the rules and
regulations thereunder and the requirements of the form. More specifically,

            Please revise your filing to include audited financial statements for the fiscal year ended
December 31, 2023 to comply with Rule 8-08 of Regulation S-X, along with related updated
financial information.

            We will provide more detailed comments relating to your registration statement
following our review of a substantive amendment that addresses these deficiencies.
            Please contact Juan Grana at 202-551-6034 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Stephen E. Fox, Esq.

SecProbe.io